We are on a mission to improve patient outcomes
We create novel medicines that benefit patients in need
About ResoTher Pharma
We target neutrophil driven inflamation and act as resolution therapy
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on discovering and developing peptide-based drugs as resolution therapy for diseases where inflammation plays a key pathological role.
Exclusive Interview with ResoTher Pharma CEO Anders Kronborg on the Future of Resolution Therapeutics
Read the full interview here
ResoTher Pharma to Go Public at Over DKK 220 Million Following Promising Heart Data
Read the full release in Danish (opens in a new [...]
From 100 Business Angels to the Stock Exchange
Interview with CEO Anders Kronborg in Bootstrapping on ResoTher Pharma’s [...]
Latest News
Exclusive Interview with ResoTher Pharma CEO Anders Kronborg on the Future of Resolution Therapeutics
Read the full interview here
ResoTher Pharma to Go Public at Over DKK 220 Million Following Promising Heart Data
Read the full release in Danish (opens in a new [...]
From 100 Business Angels to the Stock Exchange
Interview with CEO Anders Kronborg in Bootstrapping on ResoTher Pharma’s [...]